ZymeTx, Inc. - ZMTX new biotech company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ZymeTx, Inc. - ZMTX new biotech company

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Wesley Jack who wrote (2)	11/5/1997 5:25:00 PM
From: Wesley Jack	of 88

11/04 Dow Jones News Wire: ZymeTx, Inc. completed it s IPO of 2,645,000 shares for $8 a share, including the overallotment option of 345,000 shares. In a press release Tuesday, the company said total groww proceeds were $21.2 million of which $2.8 million was attributable to the exercise of the overallotment. Proceeds will fund viral diagnostic and therapeutic research, the production of a product for the 98-99 influenza season and general capital. Capital West Securities, Inc. is lead manager of the underwriting group. Co-managers are Millennium Financial Group Inc. and Comvest Partners Inc. ZymeTx develops products for diagnosis and treatment of viruses. Chaka, Wild1846

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next